FDA STANDARD OF +/-20% ADEQUATE TO ASSURE BIOEQUIVALENCE OF GENERICS, TASK FORCE MAINTAINS; +/-10% CRITERIA HAS "SOME MERIT" AS EXTRA ASSURANCE

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet